WillItSurvive
Food tech and alternative protein · China

China Feihe Limited

feihe.com ↗

China's largest infant formula maker, now facing a shrinking baby market.

Losing its protection
Assessed 26 July 2026 · Evidence as of 26 July 2026
The structural protection is eroding.
On the recordSince 26 July 2026 · Checkable from around 28 Aug 2026 · Every call on the record Checkpoint: H1 2026 results, which show whether Yili's share lead widens or Feihe stabilizes
The call

Feihe still sells the most trusted formula cans in China, but it just lost the top spot to Yili in a market with fewer babies every year.

Feihe makes infant formula and sells it through 200,000+ stores across China. It built a strong position over decades by controlling its own factories and rebuilding trust after a contamination scandal in 2008, which kept foreign brands and small competitors out. But Yili, a much larger Chinese company, just knocked Feihe from first place in early 2025, and Feihe is now spending heavily to fight back while the total baby formula market shrinks because fewer children are being born in China. The one thing that could turn this around is if Feihe can stop the bleeding and grow its adult nutrition business, but so far that is tiny and Yili keeps getting stronger.

Why
01
AI pressure: None apparent. Infant formula is a physical, regulated product; no AI agent or model competes for this shelf space. Could AI do the core job? Unlikely.
02
Bigger players: Yili (Inner Mongolia Yili Industrial Group). Yili took 18.1% retail share in H1 2025 versus Feihe's roughly 17.5%, ending Feihe's six-year run as top seller. Could a giant copy it? Probably.
03
What protects it. Vertically integrated farms and plants, 200k plus retail points, and rebuilt trust after China's 2008 formula scandal.
What would change this call
Feihe's H1 2026 results (~28 Aug 2026) show whether Yili's share gap widens. Widening gap would confirm Feihe has become permanent #2.
Feihe's adult/senior nutrition revenue share in FY2026 filings. Staying below 5% shows diversification away from shrinking infant market is failing.
Feihe's net profit trend in next earnings print after the 45.7% FY2025 drop. Continued decline would show subsidy wars are still eroding margins.
Key numbers
  • FY2025 revenue RMB18,112.6M, down 12.7% YoY (2025-12-31)
  • FY2025 net profit down 45.7% to RMB1,939.5M (2025-12-31)
  • Yili share 18.1% vs Feihe ~17.5%, H1 2025 (2025-06-30)
Named risks
  • China's declining birth rate structurally shrinks the addressable infant formula market. Severity: high
  • Subsidy wars with Yili and rivals are compressing margins, driving FY2025 profit down 45.7%. Severity: high
  • Loss of #1 retail share position to Yili after six years as market leader. Severity: medium
  • Revenue concentration risk, infant milk formula still over 92% of revenue with limited diversification. Severity: medium
  • Dependence on government pro-natal policy and subsidies to sustain demand. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Yililosing toYili's 18.1% retail share overtook Feihe's ~17.5% in H1 2025, ending Feihe's six-year lead
Biostime (H&H Group)gaining onBiostime's super-premium share rose to 15.9% by June 2025, up from 12.9% a year earlier
DanonecontestingDanone held ~14% infant formula share in 2024/2025, second-ranked behind Feihe and Yili
Junlebaogaining onJunlebao's 2024 milk-powder revenue of RMB5.37bn grew faster on value positioning, per 2026-06-22 report
Questions people ask
Is China Feihe profitable in 2025?
Yes but shrinking fast. FY2025 (year ended Dec 31, 2025) net profit fell 45.7% to RMB 1,939.5 million as revenue dropped 12.7% to RMB 18,112.6 million, per Feihe's HKEX annual results announcement dated March 26, 2026.
Did Yili overtake China Feihe in market share?
Yes. Third-party retail data cited by 36kr showed Yili's infant milk powder retail share hit 18.1% in H1 2025, overtaking Feihe, which held roughly 17.5% share in 2024 and had been the top-selling brand for six straight years through 2024.
Could AI replace China Feihe's business?
No. Feihe's moat is physical and regulatory: 13 vertically integrated factories, China's strict infant-formula registration regime, and 200,000+ retail points including mother-and-baby specialty stores. AI only touches peripheral workflows like quality control and demand forecasting, per an October 15, 2025 analysis.
Who owns China Feihe?
Chairman and CEO Leng Youbin controls China Feihe through his holding vehicle Dasheng Limited, reported near a 49% stake in the 2022 annual report. The company has traded on the Hong Kong Stock Exchange (6186) since its November 13, 2019 IPO, which raised about HKD 6.7 billion.
Is China Feihe cutting jobs?
Not significantly. As of December 31, 2025, Feihe had approximately 9,480 employees, down only 110 people (-1.15%) from the prior year, a modest trim rather than a mass layoff, per stockanalysis.com data.
Why is China Feihe's revenue falling?
Feihe cited China's shrinking birth rate and reduced government grants; FY2025 revenue fell 12.7% to RMB 18,112.6 million. It also launched a costly ~RMB 1,500 per family childbirth subsidy in April 2025 to defend share, compressing margins further.
Timeline
  • 2026-06-05AGM re-approved auditor Ernst & Young, board slate, and buyback mandates
  • 2026-03-26FY2025 results: revenue down 12.7% to RMB18,112.6m, net profit down 45.7%
  • 2025-10-15Unveiled new-generation infant formula upgrade and new SKUs
  • 2025-07-04Profit warning issued alongside RMB1bn+ share buyback plan
  • 2025-06-30H1 2025 data shows Yili overtakes Feihe with 18.1% retail share
  • 2025-04-01Launched nationwide childbirth subsidy program, ~RMB1,500 per family
  • 2024-12-31FY2024 revenue RMB20,748.6m (+6.2%); Feihe #1 for sixth straight year
  • 2019-11-13IPO on HKEX (6186), raising approximately HKD6.7 billion
  • 2013-01-01Taken private by Leng Youbin and Morgan Stanley PE Asia for ~$147 million
  • 2001-01-01Modern Feihe formed via management buyout from state-owned Zhaoguang Dairy
Revision history
26 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
RemilkNature's FyndUpside Foods
More in Food tech and alternative protein →
Sources